week 2 retatrutide Weight Loss Treatment Explained Retatrutide UK 2026: Phase 3

The FDA posted additional safety updates for Mounjaros label regarding the KwikPen injector

Deep Hydration & Skin Elasticity Support: Enriched with Hyaluronic Acid (HLA) and Biotin, this formula locks in moisture, restores firmness, and supports smooth, supple texture

NIH has released four new SBIR/STTR solicitations (first deadline for all solicitations is September 8, 2026): Parent SBIR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track SBIR awards Parent STTR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track STTR awards SBIR Phase IIB Strategic Breakthrough Award (Clinical Trial Optional) accepts Phase IIB Strategic Breakthrough SBIR awards (for Phase II awardees) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) accepts CRP awards (for Phase II awardees) Updated summaries of the research interests, budget waiver topics, and award mechanisms supported by individual Institutes and Centers (ICs) are now housed on the Small Business Funding Considerations and Contacts webpage

There is a great deal of anecdotal evidence to support these therapies

This article lists Ozempic alternatives, including options for people with type 2 diabetes and obesity